Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools provider in ...

a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease ...

Investors are likely keeping a close eye on the company’s continued investment in its pipeline and the potential positive impact these advances could have on its stock price in the future. Exact ...

Pancreatic cancer is the third leading cause of cancer death in the U.S. That’s due in part to the limited testing available ...

Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK Biobank to create the world’s first ...

In a bold move to unlock N33 trillion economic potential in Nigeria’s livestock sector, stakeholders validated the national ...

According to the latest study from Research,“ European Life Science Tools and Reagents Market, ” the market for COVID-19 diagnostics products was $14.7 billion in 2023 and expected to grow from $13.0 ...

Some were crime victims. Others lived and died in solitude. Some may have been lost hikers, runaway children, or wanderers.

Researchers at Children's Hospital of Philadelphia (CHOP) announced the creation of a new AI technology called CelloType, a ...

We speak to Morghan Lucas (MGZ, Munich) about emerging omics, cancer diagnostics her experience at the Festival of Genomics ...